Clinical Trial Update: Dose Optimization for Pulsed-dose-rate (PDR)/High-dose-rate (HDR) Brachytherapy Alone for Early Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on optimizing dose delivery for pulsed-dose-rate and high-dose-rate brachytherapy used as a standalone treatment for early breast …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: University Hospital Erlangen | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN